APA (7th ed.) Citation

ER, B., LA, W., NK, M., MK, A., MJ, L., CM, C., . . . BA, T. (2023). CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa. The CRISPR journal, 6(6), 502. https://doi.org/10.1089/crispr.2023.0039

Chicago Style (17th ed.) Citation

ER, Burnight, et al. "CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa." The CRISPR Journal 6, no. 6 (2023): 502. https://doi.org/10.1089/crispr.2023.0039.

MLA (9th ed.) Citation

ER, Burnight, et al. "CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa." The CRISPR Journal, vol. 6, no. 6, 2023, p. 502, https://doi.org/10.1089/crispr.2023.0039.